Mount Sinai researchers have discovered a previously unknown mechanism in which not-yet-malignant cells from early breast cancer tumors travel to other organs and, eventually, "turn on" and become metastatic breast cancer.
Apr 26, 2022
0
71
A new data-driven mechanistic approach that predicts cell types within tissue will help to reduce drug costs and treat diseases that were difficult to develop drugs for, according to a West Virginia University scientist.
Apr 14, 2022
0
6
A new chimeric antigen receptor (CAR) T-cell product had an acceptable safety profile and showed early signs of efficacy as a monotherapy and in combination with an mRNA vaccine in patients with solid tumors, according to ...
Apr 10, 2022
0
15
Today, treatment methods are available for cancer that complement each other. Radiation therapy is frequently used, and can be combined with surgery and chemotherapy, for example. Although treatment with ionizing radiation ...
Mar 11, 2022
0
41
Many melanoma patients are treated with drugs called BRAF or MEK inhibitors that specifically target the mutant proteins created in cancerous tumors. These inhibitors can block the tumors' ability to grow and spread.
Feb 28, 2022
0
52
Researchers at Koç University discovered why a promising class of cancer treatments fail, and their findings point to how such treatments might be made to work. The research revealed the mechanisms behind the development ...
Jan 28, 2022
0
9
Research by the Oregon State University College of Pharmacy suggests that a vaccine stimulating production of a protein critical to the skin's antioxidant network could help people bolster their defenses against skin cancer.
Jan 13, 2022
0
67
They are at the forefront in the fight against viruses, bacteria, and malignant cells: the T cells of our immune system. But the older we get, the fewer of them our body produces. Thus, how long we remain healthy also depends ...
Dec 22, 2021
0
234
New findings from a landmark study indicate there may be a way to predict treatment response in breast cancer patients even before treatment begins. The study results led by Susan G. Komen Brinker Award winner Carlos Caldas, ...
Dec 8, 2021
0
63
A combination of two targeted cancer drugs showed unprecedented, "clinically meaningful" activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by ...
Nov 25, 2021
0
151
